Biofire got FDA approval fast, but it hasn't done much good

New Post Public Reply Private Reply Replies (0) Message Board
shabby45 kraztkat #727
Biofire got FDA approval fast, but it hasn't done much good so far:

http://7online.com/health/new-test-for-diagno...ed/369875/

NEW YORK (WABC) -- When it comes to Ebola, diagnosing patients early and finding their contact immediately is critical.

But when a five-year old boy who recently came back from West Africa started to have a fever Monday morning, New York City used a test that can take up to 12 hours.

Monday night, it came back negative.

But they had another option. A new test could have given them the answer in an hour.

So why didn't the city use it?

The Food and Drug Administration has approved the use of a one-hour Ebola test that can be done right in the hospital.

But at least for now, it won't be used here in New York, not until the city and state are convinced of its accuracy.

The medical device, the size of a small printer, can accurately test blood or urine samples for Ebola in one hour:

"Time can make a difference, every hour matters," said Kirk Ririe, CEO of BioFire Defense.

The head of the Midwest company that makes the one-hour Ebola testing machine says when the FDA gave the device an Emergency Approval for use by hospitals last Saturday, he was on his way to Bellevue to assist them in its use.

"We flew to New York, received clearance, authorization while we were in the air," said Ririe.

But we've learned that city and state health officials stepped in and stopped the use of the one-hour testing device despite F-D-A's emergency approval. That meant when the 5 year old boy back from Guinea was admitted to Bellevue's Ebola Ward, the next day, it took ten hours from the time he spiked a fever till his parents, medical staff, and the public found out, he did NOT have Ebola.

"Where's the urgency here?," Eyewitness News asked U.S. Senator Charles Schumer of New York.

"Well, the sooner you can get a test result, the better, but there's another thing that has to be involved too. You need total accuracy," said Ririe.

Senator Schumer says city health officials concerned about accuracy and training have delayed the use of the one-hour Ebola tester. It's clear however that the FDA felt confident enough in the device's accuracy to give it EMERGENCY APPROVAL.

The military has been using it in West Africa since last August and dozens of hospital including Bellevue already have the device for rapid testing of the common flu and other virus:

"Has the city told you when or is there a timeline here to when they're going to be using this?," we asked.

"The city has told us they're very interested, they're going to try to move it as quickly as possible, and I've urged them to move it as quickly as possible but make sure accuracy has to be first," said Schumer.

"The benefits of a fast result for a disease like Ebola speaks for itself. Every hour left untreated is an opportunity wasted," he said.

The city's Health and Hospital Corporation says that "this new test is currently being evaluated by the State and City Health departments, along with CDC partners, to insure it would be an effective tool."

The statement goes on to say that the city's current testing process is reliable and accurate.

No word from the state health department on how it will take to approve the new Ebola test.

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dotwork's AI Leap: Acquires Arcario to Revolutionize Strategy

Updated Category News Views 108

Transformations in enterprise management are knocking at the door with Dotwork's latest move. Their strategic acquisition of Arcario Group aims to flip the lid on how companies tie strategies to their daily grind using AI. Let me level with you—this ain't about just spicing up some dashboards or workflows. We're talking about an enterprise-level overhaul in the very way...

Continue Reading
EQT's Strategic Moves in Q3 2026 Amid Strong Execution

Updated Category News Views 111

Inside EQT's Third Quarter Performance EQT Corporation has rolled out its third quarter 2026 results, and boy, they’ve been playing their cards with some finesse. The company's sporting a strong showing despite the tricky currents in the natural gas market where prices took a nosedive. What's keeping EQT upright, you ask? It's their smart marketing maneuvers and a...

Continue Reading
Small Biz Financing Soars Amid Credit Struggles

Updated Category News Views 32

Record Financing Applications, But Not All is Rosy Diving headlong into this 1West data is like clutching at a double-edged sword. On one side, we've got record-breaking numbers—48,975 financing applications in Q3 alone. That’s a staggering 25% hike over last year. But before you pop the champagne, let's pivot to the other edge: dwindling financial health. With the...

Continue Reading
Scania's Q3 Results: A Resilient Yet Uneven Ride

Updated Category News Views 71

Scania Steadies the Ship in Q3 with Robust Growth Sailing through a patchy global market, Swedish powerhouse Scania's latest quarterly figures reflect a mixed bag of results. Their performance in this third quarter of 2026 stood strong, despite some wobbles. The company showed resilience in sales and profitability, with numbers telling a tale that's a bit like a truck...

Continue Reading
Probiotics in Animal Feed: Market Reaches $8.76B by 2031

Updated Category News Views 0

Let's cut straight to the chase: the probiotics in animal feed market is steaming ahead, set to grow from a respectable $5.82 billion in 2026 to a hearty $8.76 billion by 2031. We're talking about a solid CAGR of 8.5% here. Now that's the kind of growth trajectory that gets even the most jaded traders sitting up and taking notice. Big Numbers in Livestock Nutrition...

Continue Reading
Burns Harbor Bags $11.2M to Turbocharge Operations

Updated Category News Views 120

Funding Boon for Burns Harbor It’s not every day you see a steady hand of federal money pouring into a port like Burns Harbor, and there’s an $11.2 million cherry on top from Uncle Sam to modernize this place. Yeah, you heard right—a cool eleven million to spruce up Indiana’s port operations, aimed straight at making Burns Harbor more nimble on the international...

Continue Reading
Hengrui Pharma: Innovating Oncology on Global Stage

Updated Category News Views 73

Setting the Global Stage for Chinese Pharmaceutical Innovation Ah, China is no longer just the factory of the world; it's rolling its sleeves up and getting deep into the pharma game. Hengrui Pharma, a heavyweight in China's pharmaceutical scene, just pulled off a commendable performance at the European Society for Medical Oncology (ESMO) Congress 2026 over in Madrid....

Continue Reading
Multiplier's Data Signals Global Hiring Evolution

Updated Category News Views 23

Shaking Up the Global Hiring Playbook You think you know how hiring works globally? Think again. Based on data from a whopping 38,000 cross-border hires, Multiplier's latest Talent Trends has spilled some hot new beans on how companies are rethinking their talent acquisition strategies. This isn’t just some thumb-twiddling speculation either—it’s grounded in real...

Continue Reading
isinwheel Rolls Out Black Friday Bonanza with Deals

Updated Category News Views 9

Deals That Roll — The isinwheel Advantage Black Friday isn't just about doorbuster deals on oversized TVs anymore, folks. This year, isinwheel is revving it up with a buffet of e-mobility deals that, quite frankly, shouldn't be ignored. From lightweight scooters for swift metro dashes to beefier rides for off-road escapades, they're wheeling out a host of offerings...

Continue Reading
Seasonal Hiring Booms as Firms Eye Long-Term Talent

Updated Category News Views 70

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCardia's Innovative Therapy Shows Promise in Cardiac Care

Updated Category News Views 201

BioCardia Unveils Promising Results in CardiAMP Cell Therapy BioCardia, Inc. (NASDAQ: BCDA), a pioneer in cell therapy for cardiovascular conditions, recently shared the groundbreaking results from its CardiAMP trial. This innovative cellular therapy targets chronic myocardial ischemia, a serious health issue impacting many individuals due to reduced blood flow to the...

Continue Reading
Exploring Smart Elevators: A Future of Safe and Efficient Movement

Updated Category News Views 139

Understanding the Smart Elevator Market Growth The Smart Elevator Market is rapidly evolving, driven by urbanization, energy efficiency needs, and a focus on safety. As construction of modern residential and commercial buildings continues to rise, smart elevators are becoming essential components of a contemporary infrastructure. These advancements not only enhance...

Continue Reading
Krispy Krunchy Chicken® Marks Unprecedented Growth in 2024

Updated Category News Views 317

Krispy Krunchy Chicken® Shares Successes of 2024 Krispy Krunchy Chicken, a leading player in the fast-food industry, has achieved remarkable success in 2024, closing the year with over 605 new store openings. With a vision focused on innovation and expansion, Krispy Krunchy continues to redefine the hot food concept within convenience stores. Their rapid growth reflects...

Continue Reading
Dofo Tea's Redesign Brings Tradition to Modern Life

Updated Category News Views 13

A Fresh Approach to Ancient Tea Rituals It's about time someone pulled back the velvet curtain on Chinese tea rituals for the rest of us. Dofo Tea, hailing from Chaozhou and steeped in the illustrious Teochew Gongfu Tea tradition, just gave itself a makeover. And it's not your typical slap-a-new-label-on-it kind of refresh. Instead, they've ripped open the seams of...

Continue Reading
Micron Technology's Recovery: Investing in Tomorrow's Chips

Updated Category News Views 228

Shares of Micron Technology (NASDAQ: MU) surged impressively after the company’s fiscal results showed a 93% revenue jump to $7.8 billion. This spike came despite skepticism from Wall Street analysts who had lowered price targets ahead of the earnings announcement; yet, those same analysts rushed to revise targets upwards after witnessing Micron’s performance. With...

Continue Reading